Immunogenic cell death in colon cancer prevention and therapy is a research paper published in Molecular Carcinogenesis (2020). On theSindex it has a DataRank of 0. It has been cited 118 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA215481
National Institutes of Health
Grant: R01CA203028
National Institutes of Health
Grant: R01CA217141
National Institutes of Health
Grant: R01CA236271
National Institutes of Health
Grant: R01CA247231
National Institutes of Health
Grant: U19AI068021
National Institutes of Health
Grant: 5R01CA203028-03
Role of Mcl-1 degradation in colorecal cancer therapy
National Institutes of Health
Grant: 5R01CA236271-02
Role of necroptosis in colorectal cancer therapy
National Institutes of Health
Grant: 5R01CA215481-04
Translation addiction and targeting in colon cancer
National Institutes of Health
Grant: 2U19AI068021-11
Signature-Directed, Sequential Delivery of Radiation Mitigators
National Institutes of Health
Grant: 7R01CA247231-05
Targeting defective necroptosis in colorectal cancer
FWCI
4.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2α/ATF4/CHOP and secretory autophagy pathways
Additional file 1 of Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2α/ATF4/CHOP and secretory autophagy pathways
Additional file 1 of A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia
Additional file 1 of A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia